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Monitoring home BP   
readings just got easier
This novel method of identifying patients 
with uncontrolled hypertension correlates well 
with ambulatory BP monitoring.
PRACTICE CHANGER 
Use this easy “3 out of 10 rule” to quickly 
sift through home blood pressure read-
ings and identify patients with uncontrolled 
hypertension who require pharmacologic 
management.1
STRENGTH OF RECOMMENDATION
B: Based on a single, good quality, multi-
center trial.
Sharman JE, Blizzard L, Kosmala W, et al. Pragmatic method using 
blood pressure diaries to assess blood pressure control. Ann Fam Med. 
2016;14:63-69.
ILLUSTRATIVE CASE
A 64-year-old woman presents to your office 
for a follow-up visit for her hypertension. She 
is currently managed on lisinopril 20 mg/d 
and hydrochlorothiazide 25 mg/d without any 
problems. The patient’s blood pressure (BP) 
in the office today is 148/84 mm Hg, but her 
home blood pressure (HBP) readings are much 
lower (see TABLE). Should you increase her 
lisinopril dose today?
Hypertension has been diagnosed on the basis of office readings of BP for almost a century, but the readings 
can be so inaccurate that they are not use-
ful.2 The US Preventive Services Task Force 
recommends the use of ambulatory blood 
pressure monitoring (ABPM) to accurately 
diagnose hypertension in all patients, while 
The Seventh Report of the Joint National 
Committee on Prevention, Detection, Evalu-
ation, and Treatment of High Blood Pressure 
(JNC 7) recommends ABPM for patients sus-
pected of having white-coat hypertension 
and any patient with resistant hyperten-
sion,3,4 but ABPM is not always acceptable 
to patients.5 
HBP readings, on the other hand, corre-
late well with ABPM measurements and may 
be more accurate and more predictive of ad-
verse outcomes than office measurements, 
and the process is often more tolerable to 
patients than ABPM.6-8 If the average home 
BP reading is >135/85 mm Hg, there is an 
85% probability that ambulatory BP will also 
be high.8
Guidelines recommend HBP monitoring 
for long-term follow-up of hypertension
The European Society of Hypertension 
practice guideline on HBP monitoring sug-
gests that HBP values <130/80 mm Hg may 
be considered normal, while a mean HBP 
≥135/85 mm Hg is considered elevated.9 
The guideline recommends HBP monitoring 
for 3 to 7 days prior to a patient’s follow-up 
appointment with 2 readings taken one to 
2 minutes apart in the morning and evening.9 
In a busy clinic, averaging all of these home 
values can be time-consuming. 
So how can primary care physicians 
accurately and efficiently streamline the 
process? This study sought to answer that 
question.
CONTINUED
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STUDY SUMMARY
When 3 of 10 readings are elevated, 
it’s predictive
This multicenter trial compared HBP moni-
toring to 24-hour ABPM in 286 patients with 
uncomplicated essential hypertension to 
determine the optimal percentage of HBP 
readings needed to diagnose uncontrolled 
BP (HBP ≥135/85 mm Hg). Patients were 
included if they were diagnosed with 
uncomplicated hypertension, not pregnant, 
≥18 years of age, and taking ≤3 antihyperten-
sive medications. Medication compliance 
was verified by a study nurse at a clinic visit. 
Patients were excluded if they had a signifi-
cant abnormal left ventricular mass index 
(women >59 g/m2; men >64 g/m2), coronary 
artery or renal disease, secondary hyperten-
sion, serum creatinine exceeding 1.6 mg/dL, 
aortic valve stenosis, upper 
limb obstructive atheroscle-
rosis, or BP >180/100 mm Hg.
Approximately half of 
the participants were women 
(53%), average body mass 
index was 29.4 kg/m2, and 
the average number of hyper-
tension medications being 
taken was 2.4. The patients 
were instructed to take 2 BP 
readings (one minute apart) 
at home 3 times daily, in the 
morning (between 6 am and 
10 am), at noon, and in the 
evening (between 6 pm and 
10 pm), and to record only 
the second reading for 
7 days. Only the morning 
and evening readings were 
used for analysis in the 
study. The 24-hour ABP was 
measured every 30 minutes 
during the daytime hours 
and every 60 minutes over- 
night. The primary outcome 
was to determine the optimal 
number of systolic HBP read-
ings above goal (135 mm Hg), 
from the last 10 record-
ings, that would best predict 
elevated 24-hour ABP. Sec-
ondary outcomes were 
various cardiovascular markers of target end-
organ damage. 
❚ The researchers found that if at least 
3 of the last 10 HBP readings were ele- 
vated (≥135 mm Hg systolic), the patient was 
likely to have hypertension on 24-hour ABPM 
(≥130 mm Hg). When patients had <3 HBP 
elevations out of 10 readings, their mean 
(±standard deviation [SD]) 24-hour 
ambulatory daytime systolic BP was 
132.7 (±11.1) mm Hg and their mean systolic 
HBP value was 120.4 (±9.8) mm Hg. When 
patients had ≥3 HBP elevations, their mean 
24-hour ambulatory daytime systolic BP was 
143.4 (±11.2) mm Hg and their mean systolic 
HBP value was 147.4 (±10.5) mm Hg. 
The positive and negative predictive 
values of ≥3 HBP elevations were 0.85 (95% 
confidence interval [CI], 0.78-0.91) and 
The researchers 
found that if  
at least 3 of the 
last 10 home BP 
readings were 
elevated, the  
patient was 
likely to have 
hypertension  
on 24-hour 
ambulatory 
monitoring.
TABLE 
Should you change this patient’s  
lisinopril dose?
A 64-year-old woman is currently managed on lisinopril 20 mg/d 
and hydrochlorothiazide 25 mg/d. Her blood pressure (BP) in the 
office today is 148/84 mm Hg, but her home blood pressure (HBP) 
readings, as shown below, are much lower. However, the patient’s 
HBP log notes 3 systolic readings ≥135 mm Hg, indicating uncon-
trolled hypertension. In light of Sharman, et al’s1 findings, the dose 
of lisinopril should be increased to further control this patient’s BP.
Date Time 2nd BP 
reading (mm Hg)
9/1/16 7:30 am 124/86
7:35 pm 135/88
9/2/16 6:30 am 145/96
6:35 pm 122/82
9/3/16 7:45 am 128/78
7:50 pm 116/74
9/4/16 6:15 am 130/78
6:30 pm 126/78
9/5/16 7:15 am 140/88
7:00 pm 120/84
9/6/16 6:45 am 133/86
6:30 pm 125/85
9/7/16 7:40 am 123/83
7:00 pm 124/82
BP, blood pressure.
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Patients using 
home blood  
pressure  
monitors should 
be counseled on 
how to determine 
the appropriate 
cuff size so that 
measurements 
are accurate. 
0.56 (95% CI, 0.48-0.64), respectively, for a 
24-hour systolic ABP of ≥130 mm Hg. Three 
elevations or more in HBP, out of the last 
10 readings, was also an indicator for tar-
get organ disease assessed by aortic stiff-
ness and increased left ventricular mass and 
decreased function. 
The sensitivity and specificity of ≥3 eleva-
tions for mean 24-hour ABP systolic readings 
≥130 mm Hg were 62% and 80%, respec-
tively, and for 24-hour ABP daytime systolic 
readings ≥135 mm Hg were 65% and 77%, 
respectively. 
WHAT’S NEW
Monitoring home BP  
can be simplified
The researchers found that HBP monitor-
ing correlates well with ABPM and that their 
method provides clinicians with a simple way 
(3 of the past 10 measurements ≥135 mm Hg 
systolic) to use HBP readings to make clinical 
decisions regarding  BP management.
CAVEATS
Ideal BP goals are hazy, and a lot  
of patient education is required
Conflicting information and opinions remain 
regarding the ideal intensive and standard BP 
goals in different populations.10,11 Systolic BP 
goals in this study (≥130 mm Hg for overall 
24-hour ABP and ≥135 mm Hg for 24-hour 
ABP daytime readings) are recommended by 
some experts, but are not commonly recog-
nized goals in the United States. This study 
found good correlation between HBP and 
ABPM at these goals, and it seems likely that 
this correlation could be extrapolated for 
similar BP goals. 
Other limitations are that: 1) The study 
focused only on systolic BP goals; 2) Patients 
in the study adhered to precise instructions 
on BP monitoring. HBP monitoring requires 
significant patient education on the proper 
use of the equipment and the monitoring 
schedule; and 3) While end-organ complica-
tion outcomes showed numerical decreases 
in function, the clinical significance of these 
reductions for patients is unclear. 
CHALLENGES TO IMPLEMENTATION
Cost of device and  
improper cuff sizes could be barriers
The cost of HBP monitors ($40-$60) has 
decreased significantly over time, but the 
devices are not always covered by insur-
ance and may be unobtainable for some 
people. Additionally, patients should be 
counseled on how to determine the appro-
priate cuff size to ensure the accuracy of the 
measurements. 
The British Hypertensive Society main-
tains a list of validated BP devices on their 
Web site: http://bhsoc.org/bp-monitors/ 
bp-monitors.12                         JFP
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